News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
Participant advisory group at RECOVER hub raises awareness about Long COVID
The ILLInet PARATROOPers, a a group of RECOVER study participants, collaborate with researchers to center the voices of Long COVID patients, improve RECOVER studies, and raise awareness about the condition.
Feature
46 Results
46 Results
NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment
Initially, RECOVER will test at least four potential treatments for Long COVID, with test of seven more treatments expected in the coming months.
News Release
RECOVER-VITAL enrolls first participant in trial
RECOVER-VITAL will enroll 900 people over the next six months and seek to understand whether taking Paxlovid, an antiviral drug, can improve Long COVID symptoms caused by viral persistence.
News Release
NIH Director’s blog: What Clinical Research Comes Next for Helping People with Long COVID
Three leaders at the NIH explain how patient experiences have guided and will continue to guide RECOVER's efforts to understand, diagnose, prevent, and treat Long COVID.
Feature
RECOVER program takes first steps in advancing toward clinical trials to better understand Long COVID
RECOVER will launch several clinical trials to find treatments for five of the most burdensome symptom clusters identified by people suffering from Long COVID.
Announcement
Duke Selected as RECOVER Clinical Trials Data Coordinating Center
The Duke Clinical Research Institute (DCRI) will oversee RECOVER’s efforts to find safe and effective treatments for Long COVID symptoms.News Release
NIH Infrastructure Awards to Support Research on Post-COVID Conditions
RECOVER’s Clinical Science Core (CSC) and Data Resource Core (DRC) will provide the foundation for the Initiative’s Long COVID research.
News Release